Dr Mark Pinese

Dr Mark Pinese

Conjoint Senior Lecturer

BAdvSc (Hons.), PhD

Medicine & Health
School of Clinical Medicine

Dr Pinese currently heads the Genomic Childhood Cancer Risk Team at the Children's Cancer Institute, where he researches the genomic basis of childhood cancer risk.

Previously, Dr Pinese completed his undergraduate studies at UNSW Australia on the biology of ageing, before moving to the Garvan Institute to pursue cancer research. 

At the Garvan Institute, Dr Pinese was a member of the world's largest sequencing effort in pancreatic cancer, and for his work received a PhD on the molecula...

E-mail
mpinese@ccia.org.au
Location
Lowy Cancer Research Centre

NHMRC Emerging Leadership Fellowship, 2019
Cancer Australia Priority-Driven Collaborative Cancer Research Scheme -- Comprehensively surveying the complex genetic determinants of sarcoma risk, 2018
National Computational Infrastructure Merit Allocation Scheme -- A whole genome study to map heritable risk in sarcoma, 2017

 

  • Cure Cancer Australia Researcher of the Year, 2nd Runner Up, 2020
  • Best Presentation by an Early Career Researcher, AGTA Annual Conference, 2017
  • Precision FDA Truth Challenge, Highest SNP Precision Winner, US FDA, 2016
  • University Medal in Molecular Biology, UNSW Sydney, 2005

  • Identification, estimation, and management of paediatric cancer risk.
  • Cancer risk gene discovery
  • Signatures of somatic variation and their link to biological processes
  • Bioinformatics methods development

Pathfinders Group -- Public lecture: Precision Oncology, 2018
Garvan Institute -- Public lecture: Improving Cancer Treatment Using Genomics, 2018
Probus Club -- Public lecture: Genomics at the Garvan Institute, 2017
Rare Cancers Australia CanForum16 -- Public lecture: Applying New Technologies to Disrupt Cancer, 2016